07-07-2026 18:26
via
pharmacypracticenews.com
Pediatric Iron Deficiency: New Ferritin Thresholds, and a Wider Role for Pharmacy
figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }vector juice – stock.adobe.com.By Gina ShawPediatric iron deficiency is being redefined, with significant practical implications for clinicians
Read more »
Pharmacy news
ASHP Futures 2025: What is Quiet Cracking?
As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists
Omadacycline Trial Offers a Rare Win for NTM, While Shorter TB Treatment Regimens Are Limited by Toxicities
Rethinking Inpatient IV Default for PWID With Serious Injection-Related Infections
ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling
Adult AML Survivors Face Heightened Risk for Additional Cancers
IV Iron During Acute Infection Linked to Lower Mortality, Real-World Analysis Finds
Action Steps for Reimbursement Readiness
FcRn Inhibition As a Therapeutic Class
Compassionate-Use Antifungals: What Clinicians Can Almost Access Now
Emerging Therapies For Blood Cancers
ASHP Futures 2025: Medication Safety in the AI Era
A Plague on Patient Assistance
Decnupaz Approved for Blastic Plasmacytoid Dendritic Cell Neoplasms
Desktop versie